Floatz logo

Therapeutic Asset Ratings

165 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Plavix
Thrombocytopenia
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityN/AD (30)
Recombinant Human Plasminogen Activator
Cerebral Edema
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityN/AD (30)
Tenecteplase
Cerebral Edema
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityN/AD (30)
Tirofiban
Cerebral Edema
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityN/AD (30)
Dipyridamole
Ischemic Stroke
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityN/AD (28)
Perflutren Lipid Microsphere Intravenous Suspension
Liver Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityD (28)
Salvianolic Acid
Stroke Disorder
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityN/AD (28)
Carbon Nanoparticle Suspension
Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityN/AD (26)
Ckd-581
Neutropenia (Low White Blood Cell Count)
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2NR (0)
Anti-Trbc1 Car-T Cells
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP1NR (0)
CD19 CAR-DC
B-Cell Non-Hodgkin Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP1NR (0)
Ptemizumab
Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP1NR (0)
kl002
Parkinson Disease
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEarly P1NR (0)
Metabolically Armed Egfrviii Car-T Cells
Glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEarly P1NR (0)
Pluripotent Stem Cell-Derived Mesenchymal Stem Cell Exosome Eye Drops
Dry Eye Syndrome
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP1/2NR (0)
Showing 151 to 165 of 165 assets
PreviousPage 7 of 7Next